Posts With Tag Seres Therapeutics

Showing 1 - 2 of 2 Posts

Seres Therapeutics 8-K Filing: Key Insights from January 13, 2025

•

Form 8-K

•

2025-01-13

Last updated: 9 months ago

Seres Therapeutics 8-K Filing: Key Insights from January 13, 2025

Explore Seres Therapeutics, Inc.'s crucial 8-K filing detailing significant events as of January 13, 2025. Get insights into their stock symbol MCRB and more.

Seres Therapeutics biotechnology NASDAQ MCRB 8-K filing financial reporting

Seres Therapeutics 8-K Report: Key Updates from January 9, 2025

•

Form 8-K

•

2025-01-10

Last updated: 9 months ago

Seres Therapeutics 8-K Report: Key Updates from January 9, 2025

Discover crucial insights from Seres Therapeutics' 8-K filing on January 9, 2025. Stay informed on major corporate developments and stock information.

Seres Therapeutics biotechnology NASDAQ MCRB 8-K filing eXtensible Business Reporting Language